by Don McLean | Jul 21, 2021 | News
MMS Poised for an Innovative Future with Best Clinical Research Organization Award and Two Key Executive Appointments CANTON, Mich. (July 21, 2021) – MMS Holdings Inc. (MMS) – an award-winning, data-focused CRO – announced the growth of its leadership team...
by Don McLean | Jan 29, 2021 | News
MMS HOLDINGS JOINS DECENTRALIZED TRIALS & RESEARCH ALLIANCE (DTRA) AS A FOUNDING MEMBER TO ACCELERATE THE ADOPTION OF PATIENT-FOCUSED CLINICAL TRIALS CANTON, Mich. (January 29, 2021) – MMS Holdings – an award-winning, data-focused CRO – joins a historic alliance...
by Don McLean | Oct 28, 2020 | News
MMS Academy Launches Mobile App for Accessing Pharmaceutical Industry Virtual Learning Courses from Anywhere CANTON, Mich. (October 28, 2020) – MMS Holdings (MMS) – an award-winning, data-focused CRO – announced today that its learning arm, MMS Academy, now offers...
by Don McLean | Oct 27, 2020 | Blog
FDA Advisory Committee Meeting Held to Discuss Important Topics Surrounding COVID-19 Vaccines by Samantha Hoopes, PhD, RAC The US Food and Drug Administration’s (FDA) Vaccines and Related Biological Products Advisory Committee (VRBPAC) met on Thursday, October 22,...
by Don McLean | Sep 17, 2020 | Blog
Modernizing the Functional Service Provider (FSP) Relationship: Innovations to bring value beyond “Global and Scalable” [Fill out the form below to register] Abstract: The Global Clinical Research Organization (CRO) market is expected to grow to $71.7 billion in 2024....
